The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Silencing of cZNF292 circular RNA suppresses human glioma tube formation via the Wnt/β-catenin signaling pathway
Open accessAbstract
// Ping Yang 1, * , Zhijun Qiu 2, * , Yuan Jiang 3, * , Lei Dong 4 , Wensheng Yang 5 , Chao Gu 6 , Guang Li 6 , Yu Zhu 1 1 Department of Clinical Laboratory, Tianjin Huanhu Hospital, Tianjin Key Laboratory of Cerebral Vessels and Neural Degeneration, Tianjin, China 2 Department of Neurology, Tianjin Medical University General Hospital, Tianjin Neurological Institute, Tianjin, China 3 Department of Immunology, Tianjin Key Laboratory of Cellular and Molecular Immunology, Key Laboratory of Educational Ministry of China, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China 4 Department of Pediatrics, Division of Hematology/Oncology, Aflac Cancer and Blood Disorders Center, Emory University School of Medicine, GA, USA 5 School of Pharmacal Sciences, Tianjin Medical University, Tianjin, China 6 Department of Genetics, College of Basic Medicine, Tianjin Medical University, Tianjin, China * These authors contributed equally to this work Correspondence to: Yu Zhu, email: zhuyutj@126.com Guang Li, email: ydswlg@163.com Ping Yang, email: tjhhhospitallab@126.com Chao Gu, email: guchao@tmu.edu.cn Keywords: circular RNAs, cZNF292, glioma, tube formation, proliferation Received: April 30, 2016 Accepted: August 11, 2016 Published: August 23, 2016 ABSTRACT CircRNA is a novel type of RNA molecule formed by a covalently closed loop which have no 5’-3’ polarity and possess no polyA tail and relatively stable due to the cyclic structure. Therefore, they may serve as potential targets and diagnosis biomarkers for tumor therapy. cZNF292 is an important circular oncogenic RNA and plays a critical role in the progression of tube formation. This study is aimed at exploring the role of cZNF292 in human glioma tube formation and its potential mechanism of action. We found that cZNF292 silencing suppresses tube formation by inhibiting glioma cell proliferation and cell cycle progression. Cell cycle progression in human glioma U87MG and U251 cells was halted at S/G2/M phase via the Wnt/β-catenin signaling pathway and related genes such as PRR11, Cyclin A, p-CDK2, VEGFR-1/2, p-VEGFR-1/2 and EGFR. The results suggest that cZNF292 silencing plays an important role in the tube formation process and has potential for application as a therapeutic target and biomarker in glioma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Memczak, S., Papavasileiou, P., Peters, O., & Rajewsky, N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141214 · Cited by 639
Cited by
Circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis
Legnini, I., Di Timoteo, G., Rossi, F., Morlando, M., Briganti, F., Sthandier, O., Fatica, A., Santini, T., Andronache, A., Wade, M., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.02.017 · Cited by 2,173
Circular RNA and its mechanisms in disease: From the bench to the clinic
Han, B., Chao, J., & Yao, H. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.01.010 · Cited by 788
Zhang, J., Liu, H., Hou, L., Wang, G., Zhang, R., Huang, Y., Chen, X., & Zhu, J. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0719-3 · Cited by 517
An emerging function of circRNA-miRNAs-mRNA axis in human diseases
Rong, D., Sun, H., Li, Z., Liu, S., Dong, C., Fu, K., Tang, W., & Cao, H. (2017) · Oncotarget · doi:10.18632/oncotarget.19154 · Cited by 516
Patop, I. L., & Kadener, S. (2018) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.11.007 · Cited by 468
Metadata
- Authors
- Yang, P., Qiu, Z., Jiang, Y., Dong, L., Yang, W., Gu, C., Li, G., & Zhu, Y.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2016-08-23
- Volume
- 7
- Issue
- 39
- Pages
- 63449-63455
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2509105303
- Cited by
- 199
- References
- 1
- FWCI
- 17.76
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.